Heffter Research Institute
The Heffter Research Institute (HRI) was incorporated in New Mexico in 1993 as a non-profit organization to support and promote investigation into the medical uses of psychedelic hallucinogens. It is named after the German chemist and pharmacologist Arthur Heffter, who in 1897 discovered that mescaline was the active principle in the peyote cactus, used in rituals by Natives in the American Southwest and Northern Mexico, and currently used as a sacrament by the Native American Church. The institute primarily funds academic and clinical scientists and as of the end of 2015 had funded approximately $6.7 million in research. The most recent focus of the Institute has been on clinical studies of psilocybin-assisted psychotherapy to treat end-of-life anxiety and depression, as well as alcohol and nicotine addiction.
Founding president of the Heffter Research Institute is David E. Nichols. Co-founders include Dennis McKenna.[1]
See also
Further reading
- Nichols, David E. (2014). "The Heffter Research Institute: past and hopeful future." Journal of Psychoactive Drugs, 46 (1): 20-6. Jan-Mar.
References
- ↑ "Dennis J. McKenna, PH.D". Heffter Research Institute. Retrieved 29 May 2014.